Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Blog | Stents Bioresorbable

There was an explosion of interest in bioresorbable stents immediately following the July 5, 2016 announcement that the ...

Home August 16, 2016
Home
Sponsored Content | Videos | Inventory Management

Pacemakers, stents and bandages — keeping tracking of what is on hand and accurately capturing charges can be a ...

Home August 15, 2016
Home
News | Peripheral Artery Disease (PAD)

August 10, 2016 — Mercator MedSystems Inc. announced the enrollment of the first critical limb ischemia (CLI) patients ...

Home August 10, 2016
Home
Technology | Vascular Access

August 10, 2016 — Access Scientific introduced the PowerWand XL, a companion to the PowerWand All-in-One, in July. The ...

Home August 10, 2016
Home
Cath lab radiation dose, dose reduction, cath lab staff radiation dose
Feature | Radiation Dose Management | Dave Fornell

In the past few years, concern has skyrocketed from interventional cardiologists and cath lab staff over radiation dose ...

Home August 09, 2016
Home
News | Structural Heart Occluders

August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based closure ...

Home August 08, 2016
Home
News | Heart Valve Technology

August 5, 2016 — The Centers for Medicare and Medicaid Services (CMS) has reassigned MitraClip transcatheter mitral ...

Home August 05, 2016
Home
News | Cath Lab

August 5, 2016 — Osprey Medical Inc. said it received commitments from investors for approximately $28 million ...

Home August 05, 2016
Home
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC
Feature | Dave Fornell

 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology ...

Home August 05, 2016
Home
CoreValve Evolut R, intermediate risk patients, european approval, CE mark
Feature | Heart Valve Technology

August 4, 2016 — Medtronic announced CE (Conformité Européenne) mark market clearnace for the self-expanding ...

Home August 04, 2016
Home
Sponsored Content | Whitepapers

As more procedures move into the cath lab, growing complexity is fueling an increase in procedural volume and the need ...

Home August 04, 2016
Home
Technology | Vascular Closure Devices

August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable ...

Home August 03, 2016
Home
Technology | Stents Peripheral

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates’ Gore ...

Home August 02, 2016
Home
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
Technology | Thrombectomy Devices

July 27, 2016 — Penumbra Inc. announced U.S. commercial availability of its latest thrombectomy device, the ACE68 ...

Home July 27, 2016
Home
Subscribe Now